Recorded Presentations from the NCCN 10th Annual Congress: Hematologic Malignancies™
Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients.
These activities are designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
These activities are approved for AMA PRA Category 1 Credit(s)™ and are also certified for nurses and pharmacists. Complete accreditation details are provided at the beginning of the individual activities.